Globereen Healthcare Limited Company Accounts
Globereen Healthcare Limited Company Accounts
COMPANY REGISTRATION NUMBER:
08478701
|
|
|
|
Financial Statements |
Year ended 31 May 2018
Contents |
Page |
Balance sheet |
1 |
Notes to the financial statements |
3 |
|
Balance Sheet |
2018 |
2017 |
||
Note |
£ |
£ |
£ |
Fixed assets
Investments |
4 |
|
|
|
Current assets
Debtors |
5 |
|
|
|
Cash at bank and in hand |
|
|
||
--------- |
--------- |
|||
|
|
|||
Creditors: amounts falling due within one year |
6 |
|
|
|
--------- |
--------- |
|||
Net current assets |
|
|
||
--------- |
--------- |
|||
Total assets less current liabilities |
|
|
||
Creditors: amounts falling due after more than one year |
7 |
|
|
|
--------- |
--------- |
|||
Net assets |
|
|
||
--------- |
--------- |
|||
Capital and reserves
Called up share capital |
|
|
|
Profit and loss account |
|
|
|
--------- |
--------- |
||
Shareholders funds |
|
|
|
--------- |
--------- |
||
In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.
Directors' responsibilities:
-
The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476
;
-
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements
.
|
Balance Sheet (continued) |
These financial statements were approved by the
board of directors
and authorised for issue on
28 February 2019
, and are signed on behalf of the board by:
|
|
Director |
Director |
Company registration number:
08478701
|
Notes to the Financial Statements |
Year ended 31 May 2018
1.
General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 6 Bruce Grove, London, N17 6RA.
2.
Statement of compliance
3.
Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis.
Consolidation
Investments
Fixed asset investments are initially recorded at cost, and subsequently stated at cost less any accumulated impairment losses.
Investments in associates
Investments in joint ventures
Impairment of fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date.
Financial instruments
Financial instruments are classified and accounted for, according to the substance of the contractual arrangement, as either financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.
Debtors
Basic financial assets, including trade and other debtors, are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Such assets are subsequently carried at amortised cost using the effective interest method, less any impairment.
Cash and cash equivalents
Cash and cash equivalents are represented by cash in hand, deposits held at call with financial institutions, and other short-term highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.
Creditors
Basic financial liabilities, including trade and other creditors, loans from third parties and loans from related parties, are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Such instruments are subsequently carried at amortised cost using the effective interest method, less any impairment.
4.
Investments
Shares in group undertakings |
|
£ |
|
Cost |
|
At 1 June 2017 and 31 May 2018 |
|
--------- |
|
Impairment |
|
At 1 June 2017 and 31 May 2018 |
– |
--------- |
|
Carrying amount |
|
At 31 May 2018 |
|
--------- |
|
At 31 May 2017 |
|
--------- |
|
5.
Debtors
2018 |
2017 |
|
£ |
£ |
|
Amounts owed by group undertakings and undertakings in which the company has a participating interest |
|
|
Other debtors |
|
|
--------- |
--------- |
|
|
|
|
--------- |
--------- |
|
6.
Creditors:
amounts falling due within one year
2018 |
2017 |
|
£ |
£ |
|
Bank loans and overdrafts |
|
|
Other creditors |
|
|
--------- |
--------- |
|
|
|
|
--------- |
--------- |
|
Bank loans amounting to £44,000 (2017 £42,762) have been secured by a fixed and floating charge over the company's assets.
7.
Creditors:
amounts falling due after more than one year
2018 |
2017 |
|
£ |
£ |
|
Bank loans and overdrafts |
|
|
--------- |
--------- |
|
Bank loans amounting to £652,280 (2017 £697,580) have been secured by a fixed and floating charge over the company's assets.
Included within creditors: amounts falling due after more than one year is an amount of £453,279 (2017: £503,867) in respect of liabilities payable or repayable by instalments which fall due for payment after more than five years from the reporting date.
8.
Related party transactions
No transactions with related parties were undertaken such as are required to be disclosed under Financial Reporting Standard 8.